Sisram Medical (HKG:1696) plans to repurchase up to 1% of its issued shares in the open market from time to time, subject to market conditions, according to a Thursday Hong Kong bourse filing.

The company said will decide whether to cancel the repurchased shares or hold them as treasury shares based on its capital management needs.